Shamrock Asset Management’s Biogen BIIB Stock Holding History

Shamrock Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$35K	Hold	151	–	–	0.03%	156
2019 Q2	$35K	Hold	151	–	–	0.02%	145
2019 Q1	$36K	Hold	151	–	–	0.03%	141
2018 Q4	$45K	Hold	151	–	–	0.07%	103
2018 Q3	$53K	Hold	151	–	–	0.03%	136
2018 Q2	$44K	Hold	151	–	–	0.03%	146
2018 Q1	$42K	Hold	151	–	–	0.03%	158
2017 Q4	$48K	Buy	151 +111	+278%	+$35.6K	0.03%	133
2017 Q3	$13K	Hold	40	–	–	0.01%	217
2017 Q2	$11K	Hold	40	–	–	0.01%	239
2017 Q1	$11K	Buy	+40	New	+$11.3K	0.01%	231

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Shamrock Asset Management's BIIB Position: Q3 2019 in Review

Shamrock Asset Management held its Biogen (BIIB) position steady in Q3 2019 at 151 shares worth $35K. The position accounts for 0.03% of the portfolio, ranked #156.

Shamrock Asset Management first reported a position in BIIB in Q1 2017 and has held it in 11 quarters since. The position peaked at $53K in Q3 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Shamrock Asset Management held 151 shares of Biogen worth $35K as of Q3 2019.
Shamrock Asset Management left its Biogen share count unchanged in Q3 2019.
Biogen made up 0.03% of Shamrock Asset Management's portfolio in Q3 2019, its #156 holding.
Shamrock Asset Management first reported a position in Biogen in Q1 2017 and has held it in 11 quarters since.
Shamrock Asset Management's Biogen position peaked at $53K in Q3 2018.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.